Chattanooga, Tenn.-based Erlanger Health System partnered with Shields Health Solutions, a specialty pharmacy business owned by Walgreens, to build a new specialty pharmacy program. 

After a tornado damaged one of the largest sterile injectable drug manufacturing facilities in the world, Pfizer predicted the Rocky Mount, N.C., plant will be producing again in the next few months.

Four Type 2 diabetes drugs are in CMS' lineup of the 10 drugs that face price negotiations between the agency and their makers. 

Some payers aren't covering the recently approved vaccines for respiratory syncytial virus, leaving older adults to cough up $330 out of pocket, The New York Times reported Aug. 25. 

While some hospitals are paying five to 10 times more for cancer drugs during a monthslong shortage, the U.S. saw 14 new drug supply issues since early August. 

Philadelphia-based Fox Chase Cancer Center named Dapo Amosu, PharmD, as its senior pharmacy director. 

Rite Aid is preparing to file for Chapter 11 bankruptcy this fall as it faces numerous lawsuits over its alleged role in the opioid epidemic, people familiar with the matter told The Wall Street Journal. 

The Hawaii Department of Health and Honolulu-based Kapiolani Medical Center for Women and Children have agreed to partner in purchasing a year's supply of mifepristone — equivalent to 1,000 doses, according to an Aug. 24 news release. 

Matthew Jenkins, PharmD, will become Richmond, Va.-based VCU Health's first chief pharmacy officer on Sept. 17. 

CVS unveiled Cordavis, a new subsidiary focused on biosimilars in the U.S., on Aug. 23.

Two medications, ephedrine sulfate and hydroxychloroquine sulfate, were denied inclusion on the FDA's 503B bulks list, the agency said Aug. 21. 

The FDA warned Amazon, Walmart and two other companies for selling products for molluscum contagiosum — a viral skin infection that does not have any approved over-the-counter treatments. 

The American Hospital Association stated its opposition to a drafted July 28 proposal from the U.S. House Energy and Commerce Committee that could lead to limit access to the 340B Drug Pricing Program in an Aug. 22 letter. 

More than 97 percent of health systems and hospitals said the shortage of carboplatin, a bladder cancer drug, is affecting pharmacy operations and patient care, according to a survey conducted by Vizient. 

The FDA on Aug. 21 approved Pfizer's maternal vaccine meant to protect infants from respiratory syncytial virus. 

The Joint Commission has updated medication compounding requirements for hospitals to better align with national practice standards, the organization said Aug. 21. 

The World Health Organization's list of essential medications now includes a heart polypill after a study led by a Mount Sinai researcher found the drug reduced cardiovascular mortality by 33 percent. 

Type 2 diabetes drug Ozempic and weight loss medication Wegovy cost hundreds of dollars more in the U.S. than similar nations, and Novo Nordisk is profiting so much that Denmark's economy is shifting. 

The FDA placed a partial clinical hold on Gilead Science's phase 3 study of a potential therapy for acute myeloid leukemia, the Foster City, Calif.-based biopharmaceutical company said Aug. 21. 

Glucagon-like peptide-1 receptor agonists, which include Ozempic and Mounjaro, cost between five to 10 times more in the U.S. than other wealthy nations, according to research KFF published Aug. 17.